Ernexa Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Ernexa Therapeutics Inc. (ERNA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.00 thousand shares for the 3-month period ending 2019-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2020-11-13
- Ernexa Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-09-30 was 1.00K shares.
- Ernexa Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-06-30 was 2.00K shares.
- Ernexa Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2015-09-30 was 10.00K shares, a 99.74% decline year-over-year.
- Ernexa Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2015-06-30 was 1.32M shares, a 103.08% increase year-over-year.
- Ernexa Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2012 was 452.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2019-09-30 | 1.00K shares 10-Q · filed 2020-11-13 | 3.00K shares derived: sum of 2 quarters · filed 2020-11-13 | 2.00K shares 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | 2.00K shares 10-Q · filed 2020-08-07 | 2.00K shares 10-Q · filed 2020-08-07 | |||
| 2015-09-30 | 10.00K shares 10-Q · filed 2015-11-09 | 1.33M shares derived: sum of 2 quarters · filed 2015-11-09 | 2.12M shares 10-Q · filed 2015-11-09 | ||
| 2015-06-30 | 1.32M shares 10-Q · filed 2015-08-10 | 2.10M shares 10-Q · filed 2015-08-10 | |||
| 2015-03-31 | 785.00K shares 10-Q · filed 2015-05-08 | ||||
| 2014-09-30 | 3.83M shares 10-Q · filed 2015-11-09 | 4.48M shares derived: sum of 2 quarters · filed 2015-11-09 | 5.33M shares 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | 650.00K shares 10-Q · filed 2015-08-10 | 1.50M shares 10-Q · filed 2015-08-10 | |||
| 2014-03-31 | 850.00K shares 10-Q · filed 2015-05-08 | 850.00 shares 10-Q · filed 2014-05-15 | |||
| 2013-09-30 | 127.00K shares 10-Q · filed 2014-11-07 | 925.00K shares derived: sum of 2 quarters · filed 2014-11-07 | 1.25M shares 10-Q · filed 2014-11-07 | 932.33K shares derived: sum of 4 quarters · filed 2014-11-07 | |
| 2013-06-30 | 798.00K shares 10-Q · filed 2014-08-14 | 1.13M shares 10-Q · filed 2014-08-14 | 805.33K shares derived: sum of 3 quarters · filed 2014-08-14 | 1.14M shares derived: sum of 4 quarters · filed 2014-08-14 | |
| 2013-03-31 | 330.00 shares 10-Q · filed 2014-05-15 | 330.00K shares 10-Q · filed 2013-05-13 | 7.33K shares derived: sum of 2 quarters · filed 2014-05-15 | 342.33K shares derived: sum of 3 quarters · filed 2014-05-15 | 402.33K shares derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | 7.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | 342.00K shares derived: sum of 2 quarters · filed 2013-11-14 | 402.00K shares derived: sum of 3 quarters · filed 2013-11-14 | 452.00K shares 10-K · filed 2013-03-29 | |
| 2012-09-30 | 335.00K shares 10-Q · filed 2013-11-14 | 395.00K shares derived: sum of 2 quarters · filed 2013-11-14 | 445.00K shares 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | 60.00K shares 10-Q · filed 2013-08-14 | 110.00K shares 10-Q · filed 2013-08-14 | |||
| 2012-03-31 | 50.00K shares 10-Q · filed 2013-05-13 | ||||
| 2011-09-30 | 58.30K shares 10-Q · filed 2012-11-09 | 661.30K shares derived: sum of 2 quarters · filed 2012-11-09 | 967.80K shares 10-Q · filed 2012-11-09 | ||
| 2011-06-30 | 603.00K shares 10-Q · filed 2012-08-14 | 909.50K shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |